Krazy4you Posted - 13 minutes from now

$EVH double bottom and a pump to start an uptrend would be nice here.

TOMKiLA Posted - 8 hours ago

$EVH company with great fundamentals, growing contracts and growing revenues. Costs are currently the main problem but it is an industry problem so the market still expects heavy losses. If the ceo can reduce some of the costs as already specified, this company will go between $25 and $30 per share without too many problems. Revenues I repeat are constantly growing, $2.5/7 billion in revenues 2024 with a further 15% growth next year. if you look at the history of evh, you will be able to understand that it is not the first time that it collapses so much and then recovers and makes new highs 3/4x from the lows of the period. Here, today we are at the lows.

Krazy4you Posted - 13 hours ago

$EVH looks like it’s gonna drop even more

BioStick123 Posted - 21 hours ago

$EVH entering now. Drop is overdone.

Trader_Rick_999 Posted - 22 hours ago

$EVH .786 fib retrace here

healthcareguru Posted - 23 hours ago

Dramatically Oversold HC Services names begging for a violent bounce: $EVH $SGRY $AMN …one single insider buy or new share repo announcement and these rip 20% instantly. No juice left in the short… 🔥😘 $IHF $XLV

PHILMYWALLET Posted - 23 hours ago

$EVH I may be mistaken but it's certainly looking that way

Stonkey Posted - 1 day ago

$EVH

riedela Posted - 1 day ago

$EVH

Krazy4you Posted - 1 day ago

$EVH if anyone getting in now, its going to be a long term hold.

MoerehanMs Posted - 1 day ago

$EVH what the hell is it just gonna keep falling down?

Jamesiam Posted - 1 day ago

$EVH $9 is the bottom

r202950 Posted - 1 day ago

$EVH what the hell happened today?

PHILMYWALLET Posted - 1 day ago

$EVH if this is down 3% on a green day, I can't imagine how much it'll drop when the market tanks!

Stonkey Posted - 1 day ago

$EVH Sixth day in a row that my trade account is deep red in a green market.....

TOMKiLA Posted - 2 days ago

$EVH a really funny thing is that this company is valued at half of revenue despite a strong business growth for what? a single negative news about increased costs that are certainly important but not decisive to cut 60/70% of its value. in 6/8 months I think there will be an incredible and positive trend change. goal? $25 within 8 months

MBFG09 Posted - 2 days ago

$EVH The company expects a revised adjusted EBITDA outlook of between $160 million and $175 million for the year and adjusted revenue expectations between $2.55 billion and $2.575 billion. The company is also considering a share buy-up program to increase shareholder value.

MBFG09 Posted - 2 days ago

$EVH Oppenheimer revised his forecasts on Evolent Health (NYSE:EVH) shares, reducing the price target to $28 from the previous $34, while maintaining an Outperform rating Strong buy from here

TOMKiLA Posted - 3 days ago

$EVH evolent has proven to be able to successfully manage the huge growth in revenues that is making it increasingly powerful. Clearly today there are still losses because the costs are really high but it must be said that this company could be difficult to replace so it could reduce its costs and increase net margins so as to become profitable. 🙌🏻 strong fundamentals 35/40$ soon!

TOMKiLA Posted - 4 days ago

$EVH Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Healthcare Services industry in the US. Performance of the American Healthcare Services industry Huge business opportunity

r202950 Posted - 6 days ago

$EVH

gemini112 Posted - 6 days ago

$EVH I have some Jan calls and no worries about it.

TOMKiLA Posted - 6 days ago

$EVH back in August, it was talking about the evolent sales for more than 35$ per shares! I can imagine a deal for 50 or 70$ per shares in the coming 6/8 months

TOMKiLA Posted - 1 week ago

$EVH bought 2000 shares today! Looking for the future! 🍀

MoerehanMs Posted - 1 week ago

$EVH

interestedinstocks Posted - 1 week ago

$EVH

Thestocktraderhubzee Posted - 1 week ago

WATCHLIST NOV 14 2024.. $OBIO Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target $GOVX D. Boral Capital Maintains Buy on Geovax Labs, Maintains $18 Price Target $BHVN TD Cowen Maintains Buy on Biohaven, Raises Price Target to $75 $ATEN BWS Financial Maintains Buy on A10 Networks, Raises Price Target to $24 $EVH Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $21

FMFVet Posted - 1 week ago

$EVH I read that Citigroup has maintained a "Buy" rating on EVH, with a price target of $21, which is lower than the previous target of $33. Based on this, there’s still potential for movement, but it's important to -do your own due diligence- as no one can predict exactly how the market will perform. With that said, it could set up well for a long swing trade. In my opinion it's going up. Short sellers want it to go down, so they have another opinion. The short float is above 11% now. My idea is to make money and I can not sell short, so I'm going long.

riedela Posted - 1 week ago

$EVH